Saint Joseph Hospital East
Lexington, Kentucky, United States
Hospital in Lexington, Kentucky
150 N Eagle Creek Dr, Lexington, KY 40509
About Saint Joseph Hospital East
"CHI Saint Joseph Health - Saint Joseph East is dedicated to delivering high quality, compassionate care to Lexington and nearby communities. Visit us at 150 N. Eagle Creek Drive or call (859) 967-5000 for more information."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
85
SWOG Cancer Research Network
34
Alliance for Clinical Trials in Oncology
24
ECOG-ACRIN Cancer Research Group
17
NRG Oncology
7
Wake Forest University Health Sciences
5
Children's Oncology Group
2
Gynecologic Oncology Group
2
Eastern Cooperative Oncology Group
1
GOG Foundation
1
Clinical Trials at Saint Joseph Hospital East
During the past decade, Saint Joseph Hospital East conducted 134 clinical trials. In the 10-year time frame, 134 clinical trials started and 49 clinical trials were completed, i.e. on
average, 36.6% percent of trials that started reached the finish line to date. In the past 5 years, 37 clinical trials started and 40 clinical trials were completed. i.e. 108.1%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
2007-10-12
2024-12-01
Active, not recruiting
701
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
2007-12-06
Active, not recruiting
1,052
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
2008-08-08
Active, not recruiting
403
Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
2008-03-01
Active, not recruiting
731
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
2012-06-18
Unknown status
1,070
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
2008-11-10
Active, not recruiting
2,014
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
2009-07-15
2021-06-15
Completed
506
Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
2010-02-15
2018-08-15
Completed
356
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Saint Joseph Hospital East" #1 sponsor was "National Cancer Institute (NCI)" with 85 trials, followed by "SWOG Cancer Research Network" with 34 trials
sponsored, "Alliance for Clinical Trials in Oncology" with 24 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 17 trials sponsored and "NRG Oncology"
with 17 trials sponsored. Other sponsors include 6 different institutions and
companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Joseph Hospital East"
#1 collaborator was "National Cancer Institute (NCI)" with 92 trials as a collaborator, "NRG Oncology" with 21 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Agenus Inc." with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were
collaborators in the rest 21 trials.
Clinical Trials Conditions at Saint Joseph Hospital East
According to Clinical.Site data, the most researched conditions in "Saint Joseph Hospital East" are
"Invasive Breast Carcinoma" (8 trials), "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Lung Cancer AJCC v8" (8 trials), "Recurrent Ovarian Carcinoma" (7 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials). Many other conditions were trialed in "Saint Joseph Hospital East" in a lesser frequency.
Clinical Trials Intervention Types at Saint Joseph Hospital East
Most popular intervention types in "Saint Joseph Hospital East" are "Drug" (136 trials), "Other" (108 trials), "Biological" (80 trials), "Procedure" (52 trials) and "Radiation" (23 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (48 trials), "Quality-of-Life Assessment" (46 trials), "Questionnaire Administration" (32 trials), "Computed Tomography" (31 trials) and "Nivolumab" (29 trials). Other intervention names were less common.
Clinical Trials Genders at Saint Joseph Hospital East
The vast majority of trials in "Saint Joseph Hospital East" are
143 trials for "All" genders, 30 trials for "Female" genders and 5 trials for "Male" genders.
Clinical Trials Status at Saint Joseph Hospital East
Currently, there are NaN active trials in "Saint Joseph Hospital East".
undefined are not yet recruiting,
61 are recruiting,
87 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 22 completed trials in Saint Joseph Hospital East,
3 suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Saint Joseph Hospital East, 3 "Phase 1"
clinical trials were conducted, 85 "Phase 2" clinical
trials and 89 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 6 trials that are defined as “Not Applicable".